Faecal Extraction Systems Market Share, Size, Trends, Industry Analysis Report, By Assay (Calprotectin, Albumin, Hemoglobin, Bile Acids, Others); By Indication; By Analysis Test; By End Use; By Region; Segment Forecast, 2022 - 2030
- Published Date:Mar-2022
- Pages: 116
- Format: PDF
- Report ID: PM2322
- Base Year: 2021
- Historical Data: 2018 - 2020
Report Outlook
The global faecal extraction systems market was valued at USD 1.60 billion in 2021 and is expected to grow at a CAGR of 3.6% during the forecast period. A faecal extraction system is a device/tool that is utilized for the collection of stool samples for the detection of different kinds of viruses, bacteria, or any other type of parasitic particle present in the stool.
Know more about this report: request for sample pages
The positive identification of any parasite in the stool shows the presence of an infection in the patient’s body. The increasing prevalence of IBD (Inflammatory Bowel Diseases) is anticipated to boost the growth of the faecal extraction systems market. According to CDC (Center for Diseases Control & Prevention), there was an increase in the hospitalization rate of patients with IBD in the US, from 44.2% in 2001 to 59.7% in 2018, as over 3 million individuals have been affected by this disease.
However, the high cost of the product is anticipated to hinder the growth of the faecal extraction systems market. The onset of the COVID-19 reflects the downfall of the stool extraction systems market growth owing to the unprecedented restrictions on movement along with the disruptions in personal and business activities. The disruption in the supply chain, lockdown measures, and limited consumer spending is anticipated to hamper the faecal extraction systems industry growth.
The impact of the COVID-19 outbreak is far-reaching, having negative effects on individuals, communities, and societies across the globe. People suffering from chronic health conditions are more at risk of contracting and experiencing complications from COVID-19. The growing investments towards the development of a vaccine for COVID-19, along with the increasing spending towards patient treatment, are projected to hinder the investments towards the faecal extraction systems market.
Due to the outbreak, research and academic institutions have delayed or halted their research activities in this field. Further, the decline in corporate spending and government support is anticipated to hinder the growth of the stool extraction systems industry over the coming years. However, the faecal extraction systems market is anticipated to recover at a fast rate post-COVID.
Know more about this report: request for sample pages
Industry Dynamics
Growth Drivers
The primary factor responsible for the growth of the industry is the increasing prevalence of IBD. Additionally, the faecal samples obtained by the extraction systems help identify intestinal infections and other diseases that result in poor nutrient absorption. The proper use of a faecal extraction systems assists in reducing the need for other related diagnostic tests that are inconvenient & time-consuming.
These factors are anticipated to significantly drive the growth of the stool extraction systems industry. Furthermore, according to the Australian Critical Care Journal 2021, there is a link between incontinence-related dermatitis and a faecal extraction system that is connected to low negative pressure suction equipment. Anal pouches with low negative pressure suction are efficient in collecting faecal samples from severely ill individuals with faecal incontinence.
This study is anticipated to help the future development of better faecal collection methods that reduce the danger of post-collection skin inflammation and overall pain. This link between faecal collection systems and IAD (Incontinence associated dermatitis) is anticipated to offer lucrative stool extraction systems industry growth opportunities. Moreover, the diverse applications of a single sample are propelling the industry growth as the faecal sample can be examined from several angles, including microbiological, microscopic, and others.
Report Segmentation
The market is primarily segmented on the basis of assay, indication, analysis test, end-use, and region.
|
By Assay |
By Indication |
By Analysis Test |
By End-Use |
By Region |
|
|
|
|
|
Know more about this report: request for sample pages
Insight by Assay
The Calprotectin segment is recorded to hold the larger shares in 2020 and is expected to lead the market in the forecasting years. The huge share of the segment can be attributed to the increasing number of IBD globally. According to the Morbidity and Mortality Report 2021, the prevalence of IBD in older adults has increased significantly over the past decade.
From 2001 to 2019, the number of Crohn’s disease cases increased by 3.4%, while ulcerative colitis increased by 2.8% annually. Ulcerative colitis and Crohn’s disease come under the gambit of IBS (Inflammatory Bowel Syndrome). The changes in the Calprotectin levels in the sample helps in identifying the disease that might be causing the problem.
The hemoglobin segment is projected to witness the highest growth rate in the forecasting years. The growth of the segment can be attributed to the rising prevalence of SBD (Significant Bowel Diseases) such as CRC (Colorectal Cancer), HRA (Higher Risk adenoma), and IBD. The results with f-Hb >10 microgram Hb/g faeces are defined as positive. Further, the hemoglobin test helps to guide the investigation in patients with rectal bleeding and further enables the doctor to take a better practical approach.
Geographic Overview
North America accounted for the largest revenue share in the global market in 2021. The huge share of the market in North America can be attributed to the presence of key market players coupled with the rising number of recent developments made by these companies. For instance, in March 2018, Werfen got clearance by US FDA (Food & Drug Administration) for their proprietary faecal extraction systems.
Additionally, ALPCO, one of the leading faecal extraction systems manufacturers, received the US FDA 510(k) clearance for their Calprotectin ELISA. Development such as these showcases the encouragement offered by government bodies for the development of novel systems, aiding the growth of the market. Moreover, the Europe drainage bottle market is anticipated to exhibit the highest CAGR over the forecasting years. The rising research and development activities are anticipated to boost the growth of the stool extraction systems market. The growing research on the development of new products with the help of product testing among the masses is on the rise in Europe.
For instance, Buehlmann, in partnership with Telia (developers of e-health platform), developed a telehealth system for IBD. Offering services such as comprehensive IBD patient monitoring coupled with continuous communication with healthcare professionals, providing them with the status of their test and others. Technological developments such as these are anticipated to drive the growth of the market.
Competitive Insight
Some of the major players operating in the global market include ALPCO, Alpha Laboratories, Arbor Assays, bioMérieux, BÜHLMANN, Calpro AS (Svar Lifescience), Cancax Biotech, DRG INSTRUMENTS GMBH, Promega Corporation, and Werfen.
Faecal Extraction Systems Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2021 |
USD 1.60 billion |
|
Revenue forecast in 2030 |
USD 2.19 billion |
|
CAGR |
3.6% from 2022 - 2030 |
|
Base year |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
|
Segments covered |
By Assay, By Indication, By Analysis Test, By End-Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Key companies |
ALPCO, Alpha Laboratories, Arbor Assays, bioMérieux, BÜHLMANN, Calpro AS (Svar Lifescience), Cancax Biotech, DRG INSTRUMENTS GMBH, Promega Corporation, and Werfen. |
